Circulating antibodies against Epstein-Barr virus (EBV) and p53 in EBV-positive and -negative gastric cancer

BACKGROUND: Epstein-Barr virus (EBV)-positive gastric cancers (GC) have clinicopathologic differences from EBV-negative tumors and lack TP53 mutation. Serological profiles may inform viral contribution to carcinogenesis. METHODS: We compared humoral responses of EBV-positive (n=67) and -negative (n=...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Epidemiol Biomarkers Prev
Autori principali: Camargo, M. Constanza, Kim, Kyoung-Mee, Matsuo, Keitaro, Torres, Javier, Liao, Linda M., Morgan, Douglas R., Michel, Angelika, Waterboer, Tim, Song, Minkyo, Gulley, Margaret L., Dominguez, Ricardo L., Yatabe, Yasushi, Kim, Sung, Cortes-Martinez, Gustavo F., Lissowska, Jolanta, Zabaleta, Jovanny, Pawlita, Michael, Rabkin, Charles S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8272980/
https://ncbi.nlm.nih.gov/pubmed/31719065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-19-0790
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi